Whilst mechanisms that mediate resistance to TRAIL in non-malignant cells are not entirely uncovered, it is questionable and unpredictable if TRAIL-sensitising strategies are limited to cancer cells or may also affect healthy cells. Here, TNFSF10 is linked to cancer.